1. Design, synthesis, and biological evaluation of dinuclear bismuth(III) complexes with Isoniazid-derived Schiff bases.
- Author
-
Li CH, Jiang JH, Lei YH, Li X, Yao FH, Ji MH, Zhang KW, Tao LM, Ye LJ, and Li QG
- Subjects
- Anti-Bacterial Agents chemistry, Bismuth pharmacology, Escherichia coli, Humans, Isoniazid pharmacology, Ligands, Microbial Sensitivity Tests, Spectroscopy, Fourier Transform Infrared, Staphylococcus aureus, Coordination Complexes chemistry, Schiff Bases chemistry
- Abstract
Four dinuclear bismuth(III) Schiff-base complexes bearing Schiff-base ligands have been synthesized and structurally characterized by single-crystal X-ray diffraction, elemental analysis, and spectral techniques (FT-IR, NMR and MS). The analytical data reveal the bismuth(III) complexes possess 1:1 metal-ligand ratios. In vitro biological studies have revealed that bismuth(III) complexes displayed much higher antibacterial and antitumor activities than their parent ligands, which involves two gram-negative (S. aureus, B. subtili) and two gram-positive (E. coli, P. aeruginosa) bacteria, and human gastric cancer SNU-16 cells. The power-time curves of S. pombe exposed to tested compounds were detected by bio-microcalorimetry. Some thermokinetic parameters (k, P
max, tG and Qtotal ) were derived based on the metabolic power-time curves, and their quantitative relationships with the concentrations (c) were further discussed., (Copyright © 2022 Elsevier Inc. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF